logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Longitudinal screening for prostate cancer with prostate-specific antigen.

    Article - En anglais

    Objective

    - To determine for the first 4 years of serial prostate-specific antigen (PSA) - based screening trends in compliance, prevalence of abnormal screening test results, cancer detection rates, and stage and grade of cancers detected. lJeslgn. - A community-based study of serial screening for prostate cancer with serum PSA measurements.

    Setting

    - University medical center.

    Subjects

    - A total of 10248 male volunteers at least 50 years old who were screened at 6-month intervals for a minimum of 48 months.

    Main Outcome Measures

    - The proportion of men who returned for serial screening, the proportion with elevated PSA levels, the proportion with newly elevated PSA levels, prostate cancer detection rates, and the distribution of tumor stages and grades at diagnosis.

    Results

    - At 48 months, 79% of volunteers returned for screening.

    During this interval there was a decrease in the proportion of volunteers with serum PSA levels higher than 4.0 ng/mL (from 10% to 6% - 7%), in cancer detection rates (from 3% to<1%), and in the proportion with clinically advanced cancer (from 6% to 2%). In men who underwent surgery, the proportion with high-grade cancer decreased (from 11% to 6%), and the proportion with pathologically advanced cancer was proportionately reduced but not significantly reduced (from 33% to 27%). Conclusions. (...)

    Mots-clés Pascal : Tumeur maligne, Prostate, Antigène spécifique prostate, Taux, Diagnostic, Dépistage, Homme, Etude cohorte, Appareil génital mâle pathologie, Appareil urinaire pathologie, Prostate pathologie, Exploration immunologique

    Mots-clés Pascal anglais : Malignant tumor, Prostate, Prostate specific antigen, Rate, Diagnosis, Medical screening, Human, Cohort study, Male genital diseases, Urinary system disease, Prostate disease, Immunological investigation

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0502193

    Code Inist : 002B20B02. Création : 10/04/1997.